News

October 1, 2016

First NanoMedSyn studies to improve Pompe disease treatment published by Angewandte. Angew Chem Int Ed Engl. 2016 DOI: 10.1002/anie.201607824R2  

September 22, 2016

Orphan designation was granted by European commission for the recombinant GAA-AMFA developed by NanoMedSyn for the treatment of Pompe’s disease.   EMA (EU/3/16/1726)

June 20, 2016

  Le Grand Prix « Sciences de la Vie » est décerné à NanoMedSyn au Sénat lors de la finale du 16e concours Tremplin Entreprises.

September 4, 2015

 Published by ECOMNEWS on September 1st, 2015   Publihed by BIOTECHFINANCES on September 4th, 2015   Published by Heraultjuridique.com on September 7th, 2015

April 2015

Review in Languedoc-Roussillon Magazine, L’accent du Sud, N°38, p9” on Medical Research: “Nanoparticles to fight cancer”.

December 8, 2014

Increase of capital funding of NanoMedSyn for internal R &D in lysosomal diseases and cancer.

← Previous Page